introduction to the present work. Nevertheless, to the persistent reader, the reward can be great.
The standard of production is good, with few errors remaining. The price, however, is almost shocking. Although it is generally accepted nowadays that specialist books are beyond the pocket of the individual, there is now considerable danger that they are going beyond the corporate pocket of the librarian.
P It is most suitable that a whole volume of the British Medical Bulletin should be devoted to human haemoglobin. There is no other biological molecule that has been investigated in such depth, and a distinguished team dealing with its many aspects has been assembled, each member from Britain. Dr. M. F. Perutz provides a foreword, and with his colleagues describes the structure of haemoglobin and the changes of structure associated with the change from oxy-to deoxy-haemoglobin. Many intricate details, for example the interaction of haemoglobin with 2,3-diphosphoglycerate, protons and carbon monoxide, and the oxygen equilibria and interactions involved have been investigated to a full extent. The stability of the haemoglobin is based on a delicate arrangement. Changes in the amino acid sequence can cause profound alterations, causing unstable haemoglobin diseases. This also applies to function, and notably a high oxygen affinity can be the consequence of a mutation and be followed by a rise in overall erythrocyte counts and polycythaemia.
The two most widespread haemoglobinopathies are sickle-cell disease and thalassaemia, although, in the case of the former, it is not yet fully understood what happens when deoxy-(sickle-cell) haemoglobin is precipitated within the erythrocyte. However, one begins to understand that insoluble strands of molecules are formed, and there is an increasing insight into which areas of these strands interact with one another. The thalassaemias are a group of diseases in which the haemoglobin molecule may not be formed because of inadequate production of one of the globin chains. In the resulting imbalance the surplus chains cannot form the complete haemoglobin molecule, and are precipitated as 'unstable' haemoglobins. The cause of under-production may vary from a deletion of the responsible gene to difficulties of biosynthesis all along the line. Biosynthesis of the human haemoglobin molecule is thoroughly studied, and this includes genetics in its widest sense, such as the counting of the number of haemoglobin genes, the recognition of the nucleotide sequence of globin mRNA and the coordination of the synthesis of a-and p-chains, and of haem and globin.
There is now a mounting interest in the intranuclear processes and the changes from chromatin to the more accessible DNA that can be transcribed into mRNA and the change from non-committed DNA to DNA with active globin genes.
Practical medical aspects have not been neglected, and the treatment of sicklecell anaemia is described, as well as the clinical management of thalassaemia major, the latter including intensive transfusion schemes and iron-chelating therapy, as well as for the prevention of thalassaemia by using ante-natal diagnosis.
Many inportant haemoglobinopathies are associated with changes in adult haemoglobin, i.e. with problems caused by a faulty &chain or inadequate p-chain production. Thus there is now a considerable interest in the possibleprevention of the switch from the foetal y-chain to the p-chain of adult haemoglobin, and this again is being fully considered in this volume.
This Bulletin is an account of one of the greatest triumphs of modern biology and a credit to the Editors of the British Medical Bulletin, the Scientific Editor, Professor D. J. 
